Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wei-Hwa Wu & Hsin-Neng Hsieh. (2022) Assessing the non-inferiority of a new treatment in a three-arm trial with unknown coefficient of variation. Communications in Statistics - Simulation and Computation 0:0, pages 1-18.
Read now
Read now
Martin Otava, Ziv Shkedy, Ludwig A. Hothorn, Willem Talloen, Daniel Gerhard & Adetayo Kasim. (2017) Identification of the minimum effective dose for normally distributed data using a Bayesian variable selection approach. Journal of Biopharmaceutical Statistics 27:6, pages 1073-1088.
Read now
Read now
Rebecca M. Kuiper, Daniel Gerhard & Ludwig A. Hothorn. (2014) Identification of the Minimum Effective Dose for Normally Distributed Endpoints Using a Model Selection Approach. Statistics in Biopharmaceutical Research 6:1, pages 55-66.
Read now
Read now
LudwigA. Hothorn. (2006) Multiple Comparisons and Multiple Contrasts in Randomized Dose-Response Trials—Confidence Interval Oriented Approaches. Journal of Biopharmaceutical Statistics 16:5, pages 711-731.
Read now
Read now
Articles from other publishers (25)
Meng-Chih Lee, Wei-Ya Wu, Hung-Yi Lu, Hsin-Neng Hsieh & Wei-Hwa Wu. (2023) Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial. BMC Medical Research Methodology 23:1.
Crossref
Crossref
Felix M. Kluxen, Klaus Weber, Christian Strupp, Signe M. Jensen, Ludwig A. Hothorn, Jean-Christophe Garcin & Thomas Hofmann. (2021) Using historical control data in bioassays for regulatory toxicology. Regulatory Toxicology and Pharmacology 125, pages 105024.
Crossref
Crossref
Michael J. Adjabui, Nathaniel K. Howard & Mathias Akamba. (2019) Biostatistical Assessment of Mutagenicity Studies: A Stepwise Confidence Procedure. Journal of Probability and Statistics 2019, pages 1-8.
Crossref
Crossref
John W. Green, Timothy A. Springer & Henrik Holbech. 2018. Statistical Analysis of Ecotoxicity Studies. Statistical Analysis of Ecotoxicity Studies
371
383
.
Ludwig A. Hothorn. 2016. Statistics in Toxicology Using R. Statistics in Toxicology Using R
216
223
.
John W. Green. 2014. The Role of the Study Director in Nonclinical Studies. The Role of the Study Director in Nonclinical Studies
191
224
.
Ludwig A. Hothorn. (2014) Statistical evaluation of toxicological bioassays – a review. Toxicol. Res. 3:6, pages 418-432.
Crossref
Crossref
Ludwig A. Hothorn. 2014. Regulatory Toxicology. Regulatory Toxicology
213
223
.
Mario Hasler. (2012) Multiple comparisons to both a negative and a positive control. Pharmaceutical Statistics 11:1, pages 74-81.
Crossref
Crossref
Mario Hasler, Richardus Vonk & Ludwig A. Hothorn. (2007) Assessing non‐inferiority of a new treatment in a three‐arm trial in the presence of heteroscedasticity. Statistics in Medicine 27:4, pages 490-503.
Crossref
Crossref
Patrick J. Farrell & Chul Gyu Park. (2007) Testing for Ordered Group Effects in Binary and Continuous Outcomes. Biometrical Journal 49:4, pages 585-598.
Crossref
Crossref
L.A. Hothorn. (2007) How to deal with multiple treatment or dose groups in randomized clinical trials?. Fundamental & Clinical Pharmacology 21:2, pages 137-154.
Crossref
Crossref
Christy Chuang-Stein & Zhengqing Li. 2006. Dose Finding in Drug Development. Dose Finding in Drug Development
200
219
.
Scott D. Patterson. (2005) Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team. Drug Information Journal 39:3, pages 243-265.
Crossref
Crossref
R. Webster West & Ralph L. Kodell. (2005) Changepoint alternatives to the NOAEL. Journal of Agricultural, Biological, and Environmental Statistics 10:2, pages 197-211.
Crossref
Crossref
Daniela K. Nitcheva, Walter W. Piegorsch, R. Webster West & Ralph L. Kodell. (2005) Multiplicity-Adjusted Inferences in Risk Assessment: Benchmark Analysis with Quantal Response Data. Biometrics 61:1, pages 277-286.
Crossref
Crossref
M. Hellmich & W. Lehmacher. (2005) Closure Procedures for Monotone Bi-Factorial Dose-Response Designs. Biometrics 61:1, pages 269-276.
Crossref
Crossref
Dieter Hauschke, Renate Slacik-Erben, Sabrina Hensen & Ronny Kaufmann. (2005) Biostatistical Assessment of Mutagenicity Studies by Including the Positive Control. Biometrical Journal 47:1, pages 82-87.
Crossref
Crossref
Ludwig A. Hothorn & Frank Bretz. (2019) Dose–Response and Thresholds in Mutagenicity Studies: A Statistical Testing Approach. Alternatives to Laboratory Animals 31:1_suppl, pages 97-103.
Crossref
Crossref
Dieter Hauschke & Ludwig A. Hothorn. (2019) Two-stage Testing of Safety: A Statistical View. Alternatives to Laboratory Animals 31:1_suppl, pages 77-80.
Crossref
Crossref
Dieter Hauschke, Torsten Hothorn & Juliane Schäfer. (2019) The Role of Control Groups in Mutagenicity Studies: Matching Biological and Statistical Relevance. Alternatives to Laboratory Animals 31:1_suppl, pages 65-75.
Crossref
Crossref
Frank Bretz, Ludwig A. Hothorn & Jason C. Hsu. (2003) Identifying effective and/or safe doses by stepwise confidence intervals for ratios. Statistics in Medicine 22:6, pages 847-858.
Crossref
Crossref
Markus Neuhauser. (2002) Nonparametric Identification of the Minimum Effective Dose. Drug Information Journal 36:4, pages 881-888.
Crossref
Crossref
Mervyn J. Silvapulle & Pranab K. Sen. 2001. Constrained Statistical Inference. Constrained Statistical Inference
469
524
.
Peter Bauer, Werner Brannath & Martin Posch. (2001) Multiple Testing for Identifying Effective and Safe Treatments. Biometrical Journal 43:5, pages 605-616.
Crossref
Crossref